HomeBUX • CNSX
BioMark Diagnostics Inc
Follow
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 38.56K | -7.17% |
Operating expense | 333.62K | -27.36% |
Net income | -334.77K | 17.70% |
Net profit margin | -868.11 | 11.34% |
Earnings per share | — | — |
EBITDA | -290.90K | 29.79% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.58K | -71.70% |
Total assets | 876.63K | -35.03% |
Total liabilities | 1.97M | 3.43% |
Total equity | -1.10M | — |
Shares outstanding | 90.89M | — |
Price to book | -25.50 | — |
Return on assets | -84.09% | — |
Return on capital | -174.30% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -334.77K | 17.70% |
Cash from operations | -189.85K | 62.51% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 243.79K | -62.68% |
Net change in cash | 53.94K | -62.70% |
Free cash flow | -62.81K | 83.96% |
Previous close
$0.26
Day range
$0.25 - $0.26
Year range
$0.18 - $0.32
Market cap
26.80M CAD
Avg Volume
9.82K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
About
Founded
2014
Headquarters
Website
